https://www.selleckchem.com/
Glioblastoma (GBM) is the most common and aggressive primary malignant brain tumor with a high mortality rate. Aberrant activation of signal transducers and activators of transcription (STAT) signaling results in tumor pathogenesis and progression by regulating cell cycle, cell survival and immune response. Therapeutic targets and prognostic biomarkers within the STAT family in GBM were explored using web applications and databases. High levels of STAT1/3/5A/5B/6 and low levels of STAT4 were observed in GBM patients. GBM patients expressing high STAT1/2/3/5
Mi piace
Commento
Condividi
